| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/2009 | EP2052725A2 Use of lanthanum compounds for the treatment of bone diseases |
| 04/29/2009 | EP2052724A1 Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC6 and TRPC7 ion channel |
| 04/29/2009 | EP2052723A1 Stable lyophilized preparation |
| 04/29/2009 | EP2052722A1 Methods for preventing or treating cardiac arrhythmia |
| 04/29/2009 | EP2052721A1 Use of carnosol for cartilage repair |
| 04/29/2009 | EP2052720A2 Use of at least one hydroxylamine compound for the treatment of eye disease |
| 04/29/2009 | EP2052719A1 Curative drug for neurodegenerative diseases |
| 04/29/2009 | EP2052717A1 Multiparticulate O-desmethylvenlafaxine salts and uses thereof |
| 04/29/2009 | EP2052714A1 Topical gel delivery systems for treating skin disorders |
| 04/29/2009 | EP2052697A1 Metering and packaging of controlled release medication |
| 04/29/2009 | EP2052251A1 Combination 5-ht7 receptor antagonist and serotonin reuptake inhibitor therapy |
| 04/29/2009 | EP2052011A1 Targeted polylysine dendrimer therapeutic agent |
| 04/29/2009 | EP2051990A1 Smac peptidomimetics useful as iap inhibitors |
| 04/29/2009 | EP2051987A2 Use of cd83 in combination therapies |
| 04/29/2009 | EP2051985A2 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapuetic application thereof |
| 04/29/2009 | EP2051984A1 Crystalline forms of rapamycin analogs |
| 04/29/2009 | EP2051983A1 Ntetrahydropyridothiophene derivatives for the treatment of cancer |
| 04/29/2009 | EP2051982A1 6,6-bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors |
| 04/29/2009 | EP2051981A1 1h-furo[3,2-c] pyrazole compounds useful as kinase inhibitors |
| 04/29/2009 | EP2051980A1 Pyrrolotriazine kinase inhibitors |
| 04/29/2009 | EP2051979A2 Polymorphic forms of rosiglitazone base |
| 04/29/2009 | EP2051978A2 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/29/2009 | EP2051977A2 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1 |
| 04/29/2009 | EP2051975A2 Substituted prolinamides, production thereof and their use as drugs |
| 04/29/2009 | EP2051974A1 Tetrahydrobenzothiophene derivatives |
| 04/29/2009 | EP2051971A1 Process for the preparation of pramipexole base and/or its salts |
| 04/29/2009 | EP2051969A1 Triazine derivative compound and composition for treating cancer containing them |
| 04/29/2009 | EP2051967A1 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders |
| 04/29/2009 | EP2051966A2 Heterocycles useful as inhibitors of carbonic anhydrase |
| 04/29/2009 | EP2051964A2 Fatty acid amide hydrolase inhibitors |
| 04/29/2009 | EP2051961A1 Novel isoindol derivatives as ep4 receptor agonists |
| 04/29/2009 | EP2051958A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 04/29/2009 | EP2051737A2 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 04/29/2009 | EP2051735A2 Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders |
| 04/29/2009 | EP2051731A1 Methods for reducing the incidence of mastitis |
| 04/29/2009 | EP2051728A2 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
| 04/29/2009 | EP2051724A1 A preparation for infertility treatment |
| 04/29/2009 | EP2051716A1 Induction of weight loss and the selective inhibition of ptp1b |
| 04/29/2009 | EP2051715A2 Modulators of muscarinic receptors |
| 04/29/2009 | EP2051714A1 Drug combinations for the treatment of respiratory tract diseases |
| 04/29/2009 | EP2051713A1 Prevention and treatment of microbial infection |
| 04/29/2009 | EP2051712A2 Modulators of muscarinic receptors |
| 04/29/2009 | EP2051711A1 Thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
| 04/29/2009 | EP2051710A2 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases |
| 04/29/2009 | EP2051709A2 Phenylalkyl n-hydroxyureas for combating atherosclerotic plaque |
| 04/29/2009 | EP2051708A2 Epitope reduction therapy |
| 04/29/2009 | EP2051706A1 Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10- hydroxydecy l)-1,4-benzoquinone |
| 04/29/2009 | EP2051705A2 Use of glucocorticoid receptor antagonists for treatment of infectious conditions |
| 04/29/2009 | EP2051704A1 Pharmaceutical composition with controlled active ingredient delivery for active ingredients with good solubility in water |
| 04/29/2009 | EP2051701A2 Compositions comprising calcium citrate malate and methods for making the same |
| 04/29/2009 | EP2051700A2 Compositions comprising calcium citrate malate and methods for making the same |
| 04/29/2009 | EP2051698A1 A liposomal complex of sodium carboxymethyl beta-glucan |
| 04/29/2009 | EP2051696A2 Stable liquid levetiracetam compositions and methods |
| 04/29/2009 | EP2051694A2 Pharmaceutical compositions comprising aripiprazole |
| 04/29/2009 | EP2051595A1 Stable and bioavailable compositions of isomers of carotenoids for skin and hair |
| 04/29/2009 | EP2051585A2 Materials and methods for reducing inflammation by inhibition of the atrial natriuretic peptide receptor |
| 04/29/2009 | EP2051583A2 Compositions and methods for treating vascular, autoimmune, and inflammatory diseases |
| 04/29/2009 | EP1928472A4 Composition and method for use in cartilage affecting conditions |
| 04/29/2009 | EP1904056B1 Use of a macrolide to restore corneal sensation |
| 04/29/2009 | EP1888077B1 Pharmaceutical composition containing gestagens and/or estrogens and 5-methyl-(6s)-tetrahydrofolate |
| 04/29/2009 | EP1845996A4 Compositions and methods relating to novel compounds and targets thereof |
| 04/29/2009 | EP1841437B1 9a-carbamoyl and thiocarbamoyl azalides with antimalarial activity |
| 04/29/2009 | EP1838707B1 Novel pyrrolodihydroisoquinolines as pde10 inhibitors |
| 04/29/2009 | EP1828154B1 Phenyl-piperazin methanone derivatives |
| 04/29/2009 | EP1791813B1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds |
| 04/29/2009 | EP1786429A4 Compositions and methods relating to novel compounds and targets thereof |
| 04/29/2009 | EP1784177B1 Formulation for l-tryptophane comprising carbidopa/benserazide |
| 04/29/2009 | EP1771421B1 N-hydroxyamide derivatives and use thereof |
| 04/29/2009 | EP1765775B1 Indoles useful in the treatment of inflammation |
| 04/29/2009 | EP1765311A4 Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
| 04/29/2009 | EP1758905B1 8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use in the form of a ddp-iv inhibitor |
| 04/29/2009 | EP1734969A4 Novel anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (ryr2) and uses thereof |
| 04/29/2009 | EP1720844B1 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 04/29/2009 | EP1670769B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/29/2009 | EP1663231A4 Oral itraconazole composition which is not affected by ingested food and process for preparing same |
| 04/29/2009 | EP1660482B1 3-[(2-{ 4-(hexyloxycarbonylamino-imino-methyl)-phenylamino] -methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino -propionic acid ethyl ester methane sulphonate and use thereof as a medicament |
| 04/29/2009 | EP1651592B1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 04/29/2009 | EP1572204B1 Synergistic compositions with analgesic properties comprising n-acylated 4-hydroxyphenylamine derivatives |
| 04/29/2009 | EP1558565B1 Halogenated selective androgen receptor modulators and methods of use thereof |
| 04/29/2009 | EP1552822B1 Patch |
| 04/29/2009 | EP1551403B1 5-substituted 2h-pyrazone-3-carboxylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia |
| 04/29/2009 | EP1539764B1 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists. |
| 04/29/2009 | EP1537123B1 Amino-substituted cyclohexane derivatives for the treatment of bacterial infections |
| 04/29/2009 | EP1511472B1 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/29/2009 | EP1509207B1 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release |
| 04/29/2009 | EP1485347B1 Hif hydroxylase inhibitors for use in the treatment of anaemia |
| 04/29/2009 | EP1485072B1 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion. |
| 04/29/2009 | EP1474991B1 Process for stabilising ubiquinol in foods |
| 04/29/2009 | EP1465608B1 Extended release compositions comprising as active compound venlafaxine hydrochloride |
| 04/29/2009 | EP1461319B1 Quinoline derivatives, synthesis method, and medicines containing said derivatives |
| 04/29/2009 | EP1450806B1 Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1446125B1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | EP1425022A4 Mutagenic nucleoside analogs for the treatment of viral disease |
| 04/29/2009 | EP1416937B1 Prophylactic and therapeutic use of hydroxysteroids |
| 04/29/2009 | EP1379146B1 Preparation for the prevention and/or treatment of altered bone metabolism |
| 04/29/2009 | EP1345910B1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof |
| 04/29/2009 | EP1343807B1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 04/29/2009 | EP1343475B1 Self forming, thermodynamically stable liposomes |